{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:29:14Z","timestamp":1788866954308,"version":"build-2803163510"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T00:00:00Z","timestamp":1782604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T00:00:00Z","timestamp":1782604800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004410","name":"T\u00fcrkiye Bilimsel ve Teknolojik Ara\u015ft\u0131rma Kurumu","doi-asserted-by":"publisher","award":["1919B012309108"],"award-info":[{"award-number":["1919B012309108"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ac\u0131badem University Scientific Research Projects Coordination Unit","award":["THD-2023-2167"],"award-info":[{"award-number":["THD-2023-2167"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discover Nano"],"DOI":"10.1186\/s11671-026-04750-z","type":"journal-article","created":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T17:50:47Z","timestamp":1782669047000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Tamoxifen loaded lipid nanoparticles as a novel therapeutic approach enhancing apoptotic cell death in triple negative breast cancer cells"],"prefix":"10.1186","volume":"21","author":[{"given":"Sevval","family":"Gunbay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevgi","family":"Sarigul-Ozbek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egemen","family":"Cakirli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omer Berk","family":"Sala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5621-5818","authenticated-orcid":false,"given":"Gulen Melike","family":"Demirbolat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,28]]},"reference":[{"key":"4750_CR1","doi-asserted-by":"publisher","first-page":"960","DOI":"10.3390\/genes13060960","volume":"13","author":"J Ben-Dror","year":"2022","unstructured":"Ben-Dror J, Shalamov M, Sonnenblick A. The history of early breast cancer treatment. Genes (Basel). 2022;13:960. https:\/\/doi.org\/10.3390\/genes13060960.","journal-title":"Genes (Basel)"},{"key":"4750_CR2","doi-asserted-by":"publisher","first-page":"124890","DOI":"10.1016\/j.ijpharm.2024.124890","volume":"667","author":"T Date","year":"2024","unstructured":"Date T, Katari O, Kuche K, Chaudhari D, Jain S. Launching triple-hit chemo attack on TNBC through nanoparticle-mediated codelivery of cisplatin-chlorambucil conjugate and venetoclax. Int J Pharm. 2024;667:124890. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124890.","journal-title":"Int J Pharm"},{"key":"4750_CR3","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1080\/03639045.2020.1820037","volume":"46","author":"K \u00d6zt\u00fcrk-Atar","year":"2020","unstructured":"\u00d6zt\u00fcrk-Atar K, Kaplan M, \u00c7al\u0131\u015f S. Development and evaluation of polymeric micelle containing tablet formulation for poorly water-soluble drug: tamoxifen citrate. Drug Dev Ind Pharm. 2020;46:1695\u2013704. https:\/\/doi.org\/10.1080\/03639045.2020.1820037.","journal-title":"Drug Dev Ind Pharm"},{"key":"4750_CR4","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.ijbiomac.2016.12.055","volume":"96","author":"S Javid","year":"2017","unstructured":"Javid S, Ziamajidi N, Foroughi S, Abbasalipourkabir R. Effects of tamoxifen-loaded solid lipid nanoparticles on the estrogen receptor-\u03b1 (ER-\u03b1) and vascular endothelial growth factor-A (VEGF-A) genes expression in the endometrial tissue of ovariectomized female Sprague-Dawley rats. Int J Biol Macromol. 2017;96:706\u201312. https:\/\/doi.org\/10.1016\/j.ijbiomac.2016.12.055.","journal-title":"Int J Biol Macromol"},{"key":"4750_CR5","doi-asserted-by":"publisher","first-page":"12217","DOI":"10.2147\/IJN.S548088","volume":"20","author":"R Zeinali","year":"2025","unstructured":"Zeinali R, Zaeifi D, Zolfaghari-Moghaddam SY, Paul MK, Biazar E. Current advances in nanocarriers for cancer therapy. Int J Nanomed. 2025;20:12217\u201362. https:\/\/doi.org\/10.2147\/IJN.S548088.","journal-title":"Int J Nanomed"},{"key":"4750_CR6","doi-asserted-by":"publisher","first-page":"100305","DOI":"10.1016\/j.ijpx.2024.100305","volume":"8","author":"AS Alfutaimani","year":"2024","unstructured":"Alfutaimani AS, Alharbi NK, Alahmari S, Alqabbani AA, Aldayel A. Exploring the landscape of lipid nanoparticles (LNPs): a comprehensive review of LNPs types and biological sources of lipids. Int J Pharmaceutics: X. 2024;8:100305. https:\/\/doi.org\/10.1016\/j.ijpx.2024.100305.","journal-title":"Int J Pharmaceutics: X"},{"key":"4750_CR7","doi-asserted-by":"publisher","unstructured":"Hern\u00e1ndez-Esquivel R-A, Navarro-Tovar G, Z\u00e1rate-Hern\u00e1ndez E, Aguirre-Ba\u00f1uelos P. Solid Lipid Nanoparticles (SLN). In: Sharma A, editor. Nanocomposite materials for biomedical and energy storage applications. IntechOpen; 2022. https:\/\/doi.org\/10.5772\/intechopen.102536","DOI":"10.5772\/intechopen.102536"},{"key":"4750_CR8","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1080\/17425247.2021.2011857","volume":"18","author":"O Katari","year":"2021","unstructured":"Katari O, Jain S. Solid lipid nanoparticles and nanostructured lipid carrier-based nanotherapeutics for the treatment of psoriasis. Expert Opin Drug Deliv. 2021;18:1857\u201372. https:\/\/doi.org\/10.1080\/17425247.2021.2011857.","journal-title":"Expert Opin Drug Deliv"},{"key":"4750_CR9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.2174\/1567201812666150817124133","volume":"13","author":"J Rizwanullah Md, Ahmad","year":"2016","unstructured":"Rizwanullah Md, Ahmad J, Amin S. Nanostructured lipid carriers: a novel platform for chemotherapeutics. CDD. 2016;13:4\u201326. https:\/\/doi.org\/10.2174\/1567201812666150817124133.","journal-title":"CDD"},{"key":"4750_CR10","doi-asserted-by":"publisher","first-page":"5045","DOI":"10.1080\/03067319.2022.2118054","volume":"104","author":"F Rezaei","year":"2024","unstructured":"Rezaei F, Masrournia M, Pordel M. Simultaneous determination of raloxifene and tamoxifen using dispersive micro solid-phase extraction and HPLC method in real water, human hair and serum samples. Int J Environ Anal Chem. 2024;104:5045\u201364. https:\/\/doi.org\/10.1080\/03067319.2022.2118054.","journal-title":"Int J Environ Anal Chem"},{"key":"4750_CR11","doi-asserted-by":"publisher","first-page":"470","DOI":"10.3390\/ph18040470","volume":"18","author":"OM Saka","year":"2025","unstructured":"Saka OM, Ayg\u00fcler C\u0130, \u00d6zdemir NS, S\u00fcr\u00fcc\u00fc B, \u00c7ak\u0131rl\u0131 E, Nemutlu E, et al. An experimental design approach for producing curcumin-loaded solid lipid nanoparticles. Pharmaceuticals. 2025;18:470. https:\/\/doi.org\/10.3390\/ph18040470.","journal-title":"Pharmaceuticals"},{"key":"4750_CR12","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1208\/s12249-021-02032-8","volume":"22","author":"UK Shinde","year":"2021","unstructured":"Shinde UK, Suryawanshi DG, Amin PD. Development of Gelucire\u00ae 48\/16 and TPGS Mixed Micelles and Its Pellet Formulation by Extrusion Spheronization Technique for Dissolution Rate Enhancement of Curcumin. AAPS PharmSciTech. 2021;22:182. https:\/\/doi.org\/10.1208\/s12249-021-02032-8.","journal-title":"AAPS PharmSciTech"},{"key":"4750_CR13","doi-asserted-by":"publisher","first-page":"114534","DOI":"10.1016\/j.molliq.2020.114534","volume":"320","author":"Z Shi","year":"2020","unstructured":"Shi Z, Alrobaian M, Kazmi I, Afzal O, Altamimi ASA, Al-Abbasi FA, et al. Cationic self-nanoemulsifying formulations of tamoxifen with improved biopharmaceutical attributes and anticancer activity: Systematic development and evaluation. J Mol Liq. 2020;320:114534. https:\/\/doi.org\/10.1016\/j.molliq.2020.114534.","journal-title":"J Mol Liq"},{"key":"4750_CR14","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ijpharm.2014.12.040","volume":"482","author":"P Scholz","year":"2015","unstructured":"Scholz P, Keck CM. Nanoemulsions produced by rotor\u2013stator high speed stirring. Int J Pharm. 2015;482:110\u20137. https:\/\/doi.org\/10.1016\/j.ijpharm.2014.12.040.","journal-title":"Int J Pharm"},{"key":"4750_CR15","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1016\/j.ultsonch.2014.03.025","volume":"21","author":"M Sivakumar","year":"2014","unstructured":"Sivakumar M, Tang SY, Tan KW. Cavitation technology \u2013 A greener processing technique for the generation of pharmaceutical nanoemulsions. Ultrason Sonochem. 2014;21:2069\u201383. https:\/\/doi.org\/10.1016\/j.ultsonch.2014.03.025.","journal-title":"Ultrason Sonochem"},{"key":"4750_CR16","doi-asserted-by":"publisher","first-page":"8611","DOI":"10.2147\/IJN.S534137","volume":"20","author":"A Hidayat","year":"2025","unstructured":"Hidayat A, Wardhana Y, Suwendar S, Mohammed A, Mahmoud S, Elamin K, et al. A review on QbD-driven optimization of lipid nanoparticles for oral drug delivery: from framework to formulation. IJN. 2025;20:8611\u201351. https:\/\/doi.org\/10.2147\/IJN.S534137.","journal-title":"IJN"},{"key":"4750_CR17","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1039\/C5SM02958A","volume":"12","author":"A Gupta","year":"2016","unstructured":"Gupta A, Eral HB, Hatton TA, Doyle PS. Nanoemulsions: formation, properties and applications. Soft Matter. 2016;12:2826\u201341. https:\/\/doi.org\/10.1039\/C5SM02958A.","journal-title":"Soft Matter"},{"key":"4750_CR18","doi-asserted-by":"publisher","first-page":"571","DOI":"10.3390\/jpm11060571","volume":"11","author":"MA Subhan","year":"2021","unstructured":"Subhan MA, Yalamarty SSK, Filipczak N, Parveen F, Torchilin VP. Recent advances in tumor targeting via EPR effect for cancer treatment. JPM. 2021;11:571. https:\/\/doi.org\/10.3390\/jpm11060571.","journal-title":"JPM"},{"key":"4750_CR19","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1080\/10717540590968855","volume":"12","author":"G Fontana","year":"2005","unstructured":"Fontana G, Maniscalco L, Schillaci D, Cavallaro G, Giammona G. Solid lipid nanoparticles containing tamoxifen characterization and in vitro antitumoral activity. Drug Delivery. 2005;12:385\u201392. https:\/\/doi.org\/10.1080\/10717540590968855.","journal-title":"Drug Delivery"},{"key":"4750_CR20","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3390\/pharmaceutics10020057","volume":"10","author":"M Danaei","year":"2018","unstructured":"Danaei M, Dehghankhold M, Ataei S, Hasanzadeh Davarani F, Javanmard R, Dokhani A, et al. Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics. 2018;10:57. https:\/\/doi.org\/10.3390\/pharmaceutics10020057.","journal-title":"Pharmaceutics"},{"key":"4750_CR21","doi-asserted-by":"publisher","first-page":"124799","DOI":"10.1016\/j.ijpharm.2024.124799","volume":"666","author":"K \u00d6zt\u00fcrk","year":"2024","unstructured":"\u00d6zt\u00fcrk K, Kaplan M, \u00c7al\u0131\u015f S. Effects of nanoparticle size, shape, and zeta potential on drug delivery. Int J Pharm. 2024;666:124799. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124799.","journal-title":"Int J Pharm"},{"key":"4750_CR22","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.3390\/nano14171425","volume":"14","author":"R Abbas","year":"2024","unstructured":"Abbas R, Luo J, Qi X, Naz A, Khan IA, Liu H, et al. Silver nanoparticles: synthesis, structure, properties and applications. Nanomaterials. 2024;14:1425. https:\/\/doi.org\/10.3390\/nano14171425.","journal-title":"Nanomaterials"},{"key":"4750_CR23","doi-asserted-by":"publisher","first-page":"61","DOI":"10.34172\/PS.2019.52","volume":"26","author":"M Maghsoodi","year":"2020","unstructured":"Maghsoodi M, Montazam SH, Rezvantalab H, Jelvehgari M. Response surface methodology for optimization of process variables of atorvastatin suspension preparation by microprecipitation method using desirability function. Pharm Sci. 2020;26:61\u201374. https:\/\/doi.org\/10.34172\/PS.2019.52.","journal-title":"Pharm Sci"},{"key":"4750_CR24","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.3390\/pharmaceutics16111406","volume":"16","author":"N Ameer","year":"2024","unstructured":"Ameer N, Hanif M, Abbas G, Azeem M, Mahmood K, Shahwar D, et al. Treatment of inflammatory bowel disease by using curcumin-containing self-microemulsifying delivery system: macroscopic and microscopic analysis. Pharmaceutics. 2024;16:1406. https:\/\/doi.org\/10.3390\/pharmaceutics16111406.","journal-title":"Pharmaceutics"},{"key":"4750_CR25","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1049\/iet-nbt.2019.0276","volume":"14","author":"G Poovi","year":"2020","unstructured":"Poovi G, Damodharan N. Development of tamoxifen-loaded surface-modified nanostructured lipid carrier using experimental design: in vitro and ex vivo characterisation. IET Nanobiotechnol. 2020;14:261\u201374. https:\/\/doi.org\/10.1049\/iet-nbt.2019.0276.","journal-title":"IET Nanobiotechnol"},{"key":"4750_CR26","doi-asserted-by":"publisher","unstructured":"Misdi NS, Mocktar NA, Harun NA. The effect of different concentration of brij 35 non-ionic surfactant on emulsion polymerisation of polyacrylamide (PAM). MJCHEM. 2023. https:\/\/doi.org\/10.55373\/mjchem.v25i1.84","DOI":"10.55373\/mjchem.v25i1.84"},{"key":"4750_CR27","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/jama.2018.19323","volume":"321","author":"AG Waks","year":"2019","unstructured":"Waks AG, Winer EP. Breast cancer treatment: a review. JAMA. 2019;321:288. https:\/\/doi.org\/10.1001\/jama.2018.19323.","journal-title":"JAMA"},{"key":"4750_CR28","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/S0140-6736(11)60993-8","volume":"378","author":"Early Breast Cancer Trialists\u2019 Collaborative Group (Ebctcg)","year":"2011","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative Group (Ebctcg). Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. Lancet. 2011;378:771\u201384. https:\/\/doi.org\/10.1016\/S0140-6736(11)60993-8.","journal-title":"Lancet"},{"key":"4750_CR29","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nrclinonc.2016.66","volume":"13","author":"G Bianchini","year":"2016","unstructured":"Bianchini G, Balko JM, Mayer IA, Sanders ME, Gianni L. Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease. Nat Rev Clin Oncol. 2016;13:674\u201390. https:\/\/doi.org\/10.1038\/nrclinonc.2016.66.","journal-title":"Nat Rev Clin Oncol"},{"key":"4750_CR30","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41571-021-00565-2","volume":"19","author":"G Bianchini","year":"2022","unstructured":"Bianchini G, De Angelis C, Licata L, Gianni L. Treatment landscape of triple-negative breast cancer \u2014 expanded options, evolving needs. Nat Rev Clin Oncol Nat Publishing Group. 2022;19:91\u2013113. https:\/\/doi.org\/10.1038\/s41571-021-00565-2.","journal-title":"Nat Rev Clin Oncol Nat Publishing Group"},{"key":"4750_CR31","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1743-8977-11-20","volume":"11","author":"JM Cohen","year":"2014","unstructured":"Cohen JM, Teeguarden JG, Demokritou P. An integrated approach for the in vitro dosimetry of engineered nanomaterials. Part Fibre Toxicol. 2014;11:20. https:\/\/doi.org\/10.1186\/1743-8977-11-20.","journal-title":"Part Fibre Toxicol"},{"key":"4750_CR32","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1093\/toxsci\/kfl165","volume":"95","author":"JG Teeguarden","year":"2007","unstructured":"Teeguarden JG, Hinderliter PM, Orr G, Thrall BD, Pounds JG. Particokinetics in vitro: dosimetry considerations for in vitro nanoparticle toxicity assessments. Toxicol Sci. 2007;95:300\u201312. https:\/\/doi.org\/10.1093\/toxsci\/kfl165.","journal-title":"Toxicol Sci"},{"key":"4750_CR33","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1186\/s13058-014-0431-9","volume":"16","author":"C-Y Liu","year":"2014","unstructured":"Liu C-Y, Hung M-H, Wang D-S, Chu P-Y, Su J-C, Teng T-H, et al. Tamoxifen induces apoptosis through cancerous inhibitor of protein phosphatase 2A\u2013dependent phospho-Akt inactivation in estrogen receptor\u2013negative human breast cancer cells. Breast Cancer Res. 2014;16:431. https:\/\/doi.org\/10.1186\/s13058-014-0431-9.","journal-title":"Breast Cancer Res"},{"key":"4750_CR34","doi-asserted-by":"publisher","first-page":"21164","DOI":"10.1038\/srep21164","volume":"6","author":"RT Bekele","year":"2016","unstructured":"Bekele RT, Venkatraman G, Liu R-Z, Tang X, Mi S, Benesch MGK, et al. Oxidative stress contributes to the tamoxifen-induced killing of breast cancer cells: implications for tamoxifen therapy and resistance. Sci Rep. 2016;6:21164. https:\/\/doi.org\/10.1038\/srep21164.","journal-title":"Sci Rep"},{"key":"4750_CR35","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1186\/s12885-023-10795-5","volume":"23","author":"EA Takano","year":"2023","unstructured":"Takano EA, Younes MM, Meehan K, Spalding L, Yan M, Allan P, et al. Estrogen receptor beta expression in triple negative breast cancers is not associated with recurrence or survival. BMC Cancer. 2023;23:459. https:\/\/doi.org\/10.1186\/s12885-023-10795-5.","journal-title":"BMC Cancer"},{"key":"4750_CR36","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1093\/carcin\/bgs232","volume":"33","author":"D Walerych","year":"2012","unstructured":"Walerych D, Napoli M, Collavin L, Del Sal G. The rebel angel: mutant p53 as the driving oncogene in breast cancer. Carcinogenesis. 2012;33:2007\u201317. https:\/\/doi.org\/10.1093\/carcin\/bgs232.","journal-title":"Carcinogenesis"},{"key":"4750_CR37","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1038\/s41598-025-31087-x","volume":"16","author":"A Shekari","year":"2025","unstructured":"Shekari A, Pazhang Y, Maadi H. Activation of TP53 target genes in the primary response of triple-negative breast cancer cells to doxorubicin treatment. Sci Rep Nat Publishing Group. 2025;16:1397. https:\/\/doi.org\/10.1038\/s41598-025-31087-x.","journal-title":"Sci Rep Nat Publishing Group"},{"key":"4750_CR38","doi-asserted-by":"publisher","first-page":"13599","DOI":"10.18632\/oncotarget.7300","volume":"7","author":"I Bado","year":"2016","unstructured":"Bado I, Nikolos F, Rajapaksa G, Gustafsson J-\u00c5, Thomas C. ER\u03b2 decreases the invasiveness of triple-negative breast cancer cells by regulating mutant p53 oncogenic function. Oncotarget. 2016;7:13599\u2013611. https:\/\/doi.org\/10.18632\/oncotarget.7300.","journal-title":"Oncotarget"},{"key":"4750_CR39","doi-asserted-by":"publisher","first-page":"6462","DOI":"10.1038\/onc.2017.247","volume":"36","author":"EJ Gallagher","year":"2017","unstructured":"Gallagher EJ, Zelenko Z, Neel BA, Antoniou IM, Rajan L, Kase N, et al. Elevated tumor LDLR expression accelerates LDL cholesterol-mediated breast cancer growth in mouse models of hyperlipidemia. Oncogene. 2017;36:6462\u201371. https:\/\/doi.org\/10.1038\/onc.2017.247.","journal-title":"Oncogene"},{"key":"4750_CR40","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0022-1759(95)00072-I","volume":"184","author":"I Vermes","year":"1995","unstructured":"Vermes I, Haanen C, Steffens-Nakken H, Reutellingsperger C. A novel assay for apoptosis Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunological Methods Elsevier. 1995;184:39\u201351. https:\/\/doi.org\/10.1016\/0022-1759(95)00072-I.","journal-title":"J Immunological Methods Elsevier"},{"key":"4750_CR41","doi-asserted-by":"publisher","unstructured":"Wlodkowic D, Telford W, Skommer J, Darzynkiewicz Z. Apoptosis and beyond: cytometry in studies of programmed cell death. Methods in Cell Biology. Elsevier; 2011;55\u201398. https:\/\/doi.org\/10.1016\/B978-0-12-385493-3.00004-8","DOI":"10.1016\/B978-0-12-385493-3.00004-8"},{"key":"4750_CR42","doi-asserted-by":"publisher","first-page":"e951","DOI":"10.1002\/cpz1.951","volume":"3","author":"A Costigan","year":"2023","unstructured":"Costigan A, Hollville E, Martin SJ. Discriminating between apoptosis, necrosis, necroptosis, and ferroptosis by microscopy and flow cytometry. Curr Protocols. 2023;3:e951. https:\/\/doi.org\/10.1002\/cpz1.951.","journal-title":"Curr Protocols"},{"key":"4750_CR43","doi-asserted-by":"publisher","unstructured":"Crowley LC, Marfell BJ, Scott AP, Waterhouse NJ. Quantitation of apoptosis and necrosis by annexin v binding, propidium iodide uptake, and flow cytometry. Cold Spring Harb Protoc. 2016;2016. https:\/\/doi.org\/10.1101\/pdb.prot087288. pdb.prot087288.","DOI":"10.1101\/pdb.prot087288"},{"key":"4750_CR44","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","volume":"25","author":"L Galluzzi","year":"2018","unstructured":"Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ. 2018;25:486\u2013541. https:\/\/doi.org\/10.1038\/s41418-017-0012-4.","journal-title":"Cell Death Differ"},{"key":"4750_CR45","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1182\/blood.V84.5.1415.1415","volume":"84","author":"G Koopman","year":"1994","unstructured":"Koopman G, Reutelingsperger C, Kuijten G, Keehnen R, Pals S, van Oers M. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood. 1994;84:1415\u201320. https:\/\/doi.org\/10.1182\/blood.V84.5.1415.1415.","journal-title":"Blood"},{"key":"4750_CR46","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.ijpharm.2013.03.034","volume":"454","author":"H Shete","year":"2013","unstructured":"Shete H, Patravale V. Long chain lipid based tamoxifen NLC. Part I: Preformulation studies, formulation development and physicochemical characterization. Int J Pharm. 2013;454:573\u201383. https:\/\/doi.org\/10.1016\/j.ijpharm.2013.03.034.","journal-title":"Int J Pharm"},{"key":"4750_CR47","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.ijpharm.2013.03.036","volume":"454","author":"H Shete","year":"2013","unstructured":"Shete H, Chatterjee S, De A, Patravale V. Long chain lipid based tamoxifen NLC. Part II: Pharmacokinetic, biodistribution and in vitro anticancer efficacy studies. Int J Pharm. 2013;454:584\u201392. https:\/\/doi.org\/10.1016\/j.ijpharm.2013.03.036.","journal-title":"Int J Pharm"},{"key":"4750_CR48","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.jddst.2017.07.020","volume":"41","author":"ES El-Leithy","year":"2017","unstructured":"El-Leithy ES, Abdel-Rashid RS. Lipid nanocarriers for tamoxifen citrate\/coenzyme Q10 dual delivery. J Drug Deliv Sci Technol. 2017;41:239\u201350. https:\/\/doi.org\/10.1016\/j.jddst.2017.07.020.","journal-title":"J Drug Deliv Sci Technol"},{"key":"4750_CR49","doi-asserted-by":"publisher","first-page":"096032712513225","DOI":"10.1177\/09603271251322531","volume":"44","author":"N Ghayoumipour","year":"2025","unstructured":"Ghayoumipour N, Ghafouri H. Enhancing breast cancer treatment: evaluating the efficacy of hyaluronic acid-coated tamoxifen-loaded solid lipid nanoparticles on MCF7 cells. Hum Exp Toxicol. 2025;44:09603271251322531. https:\/\/doi.org\/10.1177\/09603271251322531.","journal-title":"Hum Exp Toxicol"},{"key":"4750_CR50","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.colsurfb.2013.08.009","volume":"112","author":"CW How","year":"2013","unstructured":"How CW, Rasedee A, Manickam S, Rosli R. Tamoxifen-loaded nanostructured lipid carrier as a drug delivery system: Characterization, stability assessment and cytotoxicity. Colloids Surf B. 2013;112:393\u20139. https:\/\/doi.org\/10.1016\/j.colsurfb.2013.08.009.","journal-title":"Colloids Surf B"},{"key":"4750_CR51","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1007\/s12247-021-09539-4","volume":"17","author":"GM Demirbolat","year":"2022","unstructured":"Demirbolat GM, Aktas E, Coskun GP, Erdogan O, Cevik O. New approach to formulate methotrexate-loaded niosomes: in vitro characterization and cellular effectiveness. J Pharm Innov. 2022;17:622\u201337. https:\/\/doi.org\/10.1007\/s12247-021-09539-4.","journal-title":"J Pharm Innov"},{"key":"4750_CR52","doi-asserted-by":"publisher","first-page":"36349","DOI":"10.1038\/s41598-025-20144-0","volume":"15","author":"GM Demirbolat","year":"2025","unstructured":"Demirbolat GM, Cakirli E, Saglam AB, Sarigul-Ozbek S, Abas BI, Cevik O. pH-triggered liposomal strategy for cisplatin in lung cancer therapy. Sci Rep. 2025;15:36349. https:\/\/doi.org\/10.1038\/s41598-025-20144-0.","journal-title":"Sci Rep"},{"key":"4750_CR53","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1049\/iet-nbt.2019.0276","volume":"14","author":"G Poovi","year":"2020","unstructured":"Poovi G, Damodharan N. Development of tamoxifen-loaded surface\u2010modified nanostructured lipid carrier using experimental design: in vitro and ex vivo characterisation. IET Nanobiotechnol. 2020;14:261\u201374. https:\/\/doi.org\/10.1049\/iet-nbt.2019.0276.","journal-title":"IET Nanobiotechnol"},{"key":"4750_CR54","doi-asserted-by":"publisher","first-page":"106163","DOI":"10.1016\/j.jmbbm.2023.106163","volume":"148","author":"AC Puigmal","year":"2023","unstructured":"Puigmal AC, Ayran M, Ulag S, Altan E, Guncu MM, Aksu B, et al. Fucoidan-loaded electrospun Polyvinyl-alcohol\/Chitosan nanofibers with enhanced antibacterial activity for skin tissue engineering. J Mech Behav Biomed Mater. 2023;148:106163. https:\/\/doi.org\/10.1016\/j.jmbbm.2023.106163.","journal-title":"J Mech Behav Biomed Mater"},{"key":"4750_CR55","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.3390\/polym17182497","volume":"17","author":"R \u00c7etin","year":"2025","unstructured":"\u00c7etin R, Ates B, Gok O, Benli B. pH-sensitive naproxen delivery via ZIF and Kaolin@ZIF nanocarriers in 3D-printed PLA\u2013gelatin hydrogels. Polymers. 2025;17:2497. https:\/\/doi.org\/10.3390\/polym17182497.","journal-title":"Polymers"}],"container-title":["Discover Nano"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11671-026-04750-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s11671-026-04750-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11671-026-04750-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T17:50:49Z","timestamp":1782669049000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s11671-026-04750-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,28]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4750"],"URL":"https:\/\/doi.org\/10.1186\/s11671-026-04750-z","relation":{},"ISSN":["2731-9229"],"issn-type":[{"value":"2731-9229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,28]]},"assertion":[{"value":"6 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"295"}}